Cargando…
B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer
B cells can act as potent suppressors of anti-tumor T cell immunity, presenting a mechanism of resistance to immunotherapy. In pancreatic ductal adenocarcinoma, B cells can display a T cell-suppressive or regulatory phenotype centered on the expression of the cytokine Interleukin 35 (IL-35). While B...
Autores principales: | Michaud, Daniel, Mirlekar, Bhalchandra, Steward, Colleen, Bishop, Gail, Pylayeva-Gupta, Yuliya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761795/ https://www.ncbi.nlm.nih.gov/pubmed/35046933 http://dx.doi.org/10.3389/fimmu.2021.745873 |
Ejemplares similares
-
IL-12 Family Cytokines in Cancer and Immunotherapy
por: Mirlekar, Bhalchandra, et al.
Publicado: (2021) -
Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity
por: Mirlekar, Bhalchandra, et al.
Publicado: (2022) -
Chromatin Remodeling Protein SMAR1 Is a Critical Regulator of T Helper Cell Differentiation and Inflammatory Diseases
por: Mirlekar, Bhalchandra, et al.
Publicado: (2017) -
Rab27a plays a dual role in metastatic propensity of pancreatic cancer
por: Kren, Nancy, et al.
Publicado: (2020) -
Impact of IL-23 in prostate cancer
por: Mirlekar, Bhalchandra
Publicado: (2021)